Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer

[Vaccines for the treatment of non-small cell lung cancer]

Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients‘ preference-based study (PPPS)

Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways

Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells

Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.

Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC

Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC

Phase I Trial of Intratumoral Injection of Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8 T-cell Infiltration

Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis